These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
586 related articles for article (PubMed ID: 24146797)
1. Podocalyxin-like protein is expressed in glioblastoma multiforme stem-like cells and is associated with poor outcome. Binder ZA; Siu IM; Eberhart CG; Ap Rhys C; Bai RY; Staedtke V; Zhang H; Smoll NR; Piantadosi S; Piccirillo SG; Dimeco F; Weingart JD; Vescovi A; Olivi A; Riggins GJ; Gallia GL PLoS One; 2013; 8(10):e75945. PubMed ID: 24146797 [TBL] [Abstract][Full Text] [Related]
2. Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells. Stangeland B; Mughal AA; Grieg Z; Sandberg CJ; Joel M; Nygård S; Meling T; Murrell W; Vik Mo EO; Langmoen IA Oncotarget; 2015 Sep; 6(28):26192-215. PubMed ID: 26295306 [TBL] [Abstract][Full Text] [Related]
3. miR128-1 inhibits the growth of glioblastoma multiforme and glioma stem-like cells via targeting BMI1 and E2F3. Shan ZN; Tian R; Zhang M; Gui ZH; Wu J; Ding M; Zhou XF; He J Oncotarget; 2016 Nov; 7(48):78813-78826. PubMed ID: 27705931 [TBL] [Abstract][Full Text] [Related]
4. A Sox2:miR-486-5p Axis Regulates Survival of GBM Cells by Inhibiting Tumor Suppressor Networks. Lopez-Bertoni H; Kotchetkov IS; Mihelson N; Lal B; Rui Y; Ames H; Lugo-Fagundo M; Guerrero-Cazares H; Quiñones-Hinojosa A; Green JJ; Laterra J Cancer Res; 2020 Apr; 80(8):1644-1655. PubMed ID: 32094299 [TBL] [Abstract][Full Text] [Related]
5. The transcript ENST00000444125 of lncRNA LINC01503 promotes cancer stem cell properties of glioblastoma cells via reducing FBXW1 mediated GLI2 degradation. Wei P; Jiang J; Xiao M; Zeng M; Liu X; Zhao B; Chen F Exp Cell Res; 2022 Mar; 412(1):113009. PubMed ID: 34990616 [TBL] [Abstract][Full Text] [Related]
6. Functional genomics analyses of RNA-binding proteins reveal the splicing regulator SNRPB as an oncogenic candidate in glioblastoma. Correa BR; de Araujo PR; Qiao M; Burns SC; Chen C; Schlegel R; Agarwal S; Galante PA; Penalva LO Genome Biol; 2016 Jun; 17(1):125. PubMed ID: 27287018 [TBL] [Abstract][Full Text] [Related]
7. Bmi1 regulates human glioblastoma stem cells through activation of differential gene networks in CD133+ brain tumor initiating cells. Vora P; Seyfrid M; Venugopal C; Qazi MA; Salim S; Isserlin R; Subapanditha M; O'Farrell E; Mahendram S; Singh M; Bakhshinyan D; Chokshi C; McFarlane N; Dvorkin-Gheva A; Brown KR; Murty N; Moffat J; Bader GD; Singh SK J Neurooncol; 2019 Jul; 143(3):417-428. PubMed ID: 31115870 [TBL] [Abstract][Full Text] [Related]
8. Differential expression of miR16 in glioblastoma and glioblastoma stem cells: their correlation with proliferation, differentiation, metastasis and prognosis. Tian R; Wang J; Yan H; Wu J; Xu Q; Zhan X; Gui Z; Ding M; He J Oncogene; 2017 Oct; 36(42):5861-5873. PubMed ID: 28628119 [TBL] [Abstract][Full Text] [Related]
9. Molecular heterogeneity in a patient-derived glioblastoma xenoline is regulated by different cancer stem cell populations. Garner JM; Ellison DW; Finkelstein D; Ganguly D; Du Z; Sims M; Yang CH; Interiano RB; Davidoff AM; Pfeffer LM PLoS One; 2015; 10(5):e0125838. PubMed ID: 25955030 [TBL] [Abstract][Full Text] [Related]
10. Involvement of miRNAs in the differentiation of human glioblastoma multiforme stem-like cells. Aldaz B; Sagardoy A; Nogueira L; Guruceaga E; Grande L; Huse JT; Aznar MA; Díez-Valle R; Tejada-Solís S; Alonso MM; Fernandez-Luna JL; Martinez-Climent JA; Malumbres R PLoS One; 2013; 8(10):e77098. PubMed ID: 24155920 [TBL] [Abstract][Full Text] [Related]
11. From the Cover: Neutralization of terminal differentiation in gliomagenesis. Hu J; Ho AL; Yuan L; Hu B; Hua S; Hwang SS; Zhang J; Hu T; Zheng H; Gan B; Wu G; Wang YA; Chin L; DePinho RA Proc Natl Acad Sci U S A; 2013 Sep; 110(36):14520-7. PubMed ID: 23918370 [TBL] [Abstract][Full Text] [Related]
12. High Podocalyxin levels promote cell viability partially through up-regulation of Annexin A2. San IV; Prost G; Williams JA; Moss SE; Nuber UA Biochem Biophys Res Commun; 2016 Sep; 478(2):573-9. PubMed ID: 27470587 [TBL] [Abstract][Full Text] [Related]
14. ER stress and UPR activation in glioblastoma: identification of a noncanonical PERK mechanism regulating GBM stem cells through SOX2 modulation. Peñaranda-Fajardo NM; Meijer C; Liang Y; Dijkstra BM; Aguirre-Gamboa R; den Dunnen WFA; Kruyt FAE Cell Death Dis; 2019 Sep; 10(10):690. PubMed ID: 31534165 [TBL] [Abstract][Full Text] [Related]
15. SLC7A11 Overexpression in Glioblastoma Is Associated with Increased Cancer Stem Cell-Like Properties. Polewski MD; Reveron-Thornton RF; Cherryholmes GA; Marinov GK; Aboody KS Stem Cells Dev; 2017 Sep; 26(17):1236-1246. PubMed ID: 28610554 [TBL] [Abstract][Full Text] [Related]
16. Different Effects of BORIS/CTCFL on Stemness Gene Expression, Sphere Formation and Cell Survival in Epithelial Cancer Stem Cells. Alberti L; Losi L; Leyvraz S; Benhattar J PLoS One; 2015; 10(7):e0132977. PubMed ID: 26185996 [TBL] [Abstract][Full Text] [Related]
17. Sox2, a stemness gene, regulates tumor-initiating and drug-resistant properties in CD133-positive glioblastoma stem cells. Song WS; Yang YP; Huang CS; Lu KH; Liu WH; Wu WW; Lee YY; Lo WL; Lee SD; Chen YW; Huang PI; Chen MT J Chin Med Assoc; 2016 Oct; 79(10):538-45. PubMed ID: 27530866 [TBL] [Abstract][Full Text] [Related]
18. The effects of type I interferon on glioblastoma cancer stem cells. Du Z; Cai C; Sims M; Boop FA; Davidoff AM; Pfeffer LM Biochem Biophys Res Commun; 2017 Sep; 491(2):343-348. PubMed ID: 28728846 [TBL] [Abstract][Full Text] [Related]
19. Girdin maintains the stemness of glioblastoma stem cells. Natsume A; Kato T; Kinjo S; Enomoto A; Toda H; Shimato S; Ohka F; Motomura K; Kondo Y; Miyata T; Takahashi M; Wakabayashi T Oncogene; 2012 May; 31(22):2715-24. PubMed ID: 22020337 [TBL] [Abstract][Full Text] [Related]
20. Molecular properties of CD133+ glioblastoma stem cells derived from treatment-refractory recurrent brain tumors. Liu Q; Nguyen DH; Dong Q; Shitaku P; Chung K; Liu OY; Tso JL; Liu JY; Konkankit V; Cloughesy TF; Mischel PS; Lane TF; Liau LM; Nelson SF; Tso CL J Neurooncol; 2009 Aug; 94(1):1-19. PubMed ID: 19468690 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]